Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population
- PMID: 24669190
- PMCID: PMC3962317
- DOI: 10.2147/CIA.S57714
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population
Abstract
Background: The modifications of cholesterol metabolism associated with aging are ill-defined. The objective of this study was to define age-associated alterations of the different metabolic pathways controlling cholesterol homeostasis by analyzing circulating sterols.
Methods: We analyzed serum samples collected from 201 adult (75 male, 126 female) subjects within the epidemiological MICOL study (Multicentrica Italiana Colelitiasi). The age range was 38-79 years; 103 had evidence of gallstones. The concentrations of the different sterols, recognized as markers of the main pathways of cholesterol homeostasis, were analyzed by gas chromatography-mass spectrometry, including lathosterol (synthesis), campesterol and sitosterol (absorption), and 7α-hydroxy-4-cholesten-3-one (degradation to bile acids).
Results: A significant direct correlation was detected between age and cholesterol levels (r =0.34, P<0.01). The lathosterol/cholesterol ratio was lower in older age quartiles (P<0.05 by analysis of variance), with an inverse correlation between the lathosterol/cholesterol ratio and age (r=-0.32, P<0.01). Such correlation was particularly evident in females. The campesterol/cholesterol and sitosterol/cholesterol ratios were inversely correlated with aging in control, but not in gallstone patients. The levels of 7α-hydroxy-4-cholesten-3-one were not correlated with age.
Conclusion: These data show a reduction of cholesterol synthesis with aging which is associated with increased circulating cholesterol levels. The finding might be related to a reduced metabolic need for cholesterol in advancing age, leading to a downregulation of the main mechanisms of cholesterol intake in the liver. A different age-related behavior was observed in gallstone-free versus gallstone patients regarding cholesterol absorption. The possible implications in terms of the pharmacological management of hypercholesterolemia in the elderly remain to be defined.
Keywords: aging; cardiovascular risk; cholesterol metabolism; cholesterol synthesis; gallstone disease.
Figures
Similar articles
-
Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.BMC Gastroenterol. 2013 Feb 13;13:30. doi: 10.1186/1471-230X-13-30. BMC Gastroenterol. 2013. PMID: 23406058 Free PMC article.
-
Non-cholesterol sterols in different forms of primary hyperlipemias.Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):231-6. doi: 10.1016/j.numecd.2010.05.010. Epub 2010 Aug 13. Nutr Metab Cardiovasc Dis. 2012. PMID: 20708389
-
Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia.Life Sci. 2012 Jun 6;90(21-22):846-50. doi: 10.1016/j.lfs.2012.03.038. Epub 2012 Apr 24. Life Sci. 2012. PMID: 22554491 Clinical Trial.
-
[Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].Orv Hetil. 2007 Apr 8;148(14):627-32. doi: 10.1556/OH.2007.28065. Orv Hetil. 2007. PMID: 17403635 Review. Hungarian.
-
Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome.Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):620-7. doi: 10.1016/j.numecd.2011.04.010. Epub 2011 Aug 19. Nutr Metab Cardiovasc Dis. 2011. PMID: 21855307 Review.
Cited by
-
Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population.Heliyon. 2022 Aug 3;8(8):e10050. doi: 10.1016/j.heliyon.2022.e10050. eCollection 2022 Aug. Heliyon. 2022. PMID: 36033296 Free PMC article.
-
Effects of natural aging and gender on pro-inflammatory markers.Braz J Med Biol Res. 2019;52(9):e8392. doi: 10.1590/1414-431X20198392. Epub 2019 Aug 12. Braz J Med Biol Res. 2019. PMID: 31411315 Free PMC article.
-
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients.Clin Interv Aging. 2021 Jul 2;16:1251-1264. doi: 10.2147/CIA.S305933. eCollection 2021. Clin Interv Aging. 2021. PMID: 34239298 Free PMC article.
-
Evidence for a role of human blood-borne factors in mediating age-associated changes in molecular circadian rhythms.Elife. 2024 Nov 1;12:RP88322. doi: 10.7554/eLife.88322. Elife. 2024. PMID: 39485282 Free PMC article.
-
Lipid lowering in patients 75 years and older.World J Cardiol. 2021 Oct 26;13(10):526-532. doi: 10.4330/wjc.v13.i10.526. World J Cardiol. 2021. PMID: 34754397 Free PMC article. Review.
References
-
- Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252–M257. - PubMed
-
- Aronow WS. Lipids in the elderly. Rev Endocr Metab Dis. 2004;5:359–364. - PubMed
-
- Grundy SM, Cleeman JI, Rifkind BM, Kuller LH. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med. 1999;159:1670–1678. - PubMed
-
- Lemaitre RN, Psaty BM, Heckbert SR, Kronmal RA, Newman AB, Burke GL. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Intern Med. 2002;162:1395–1400. - PubMed
-
- Grundy SM. Statin therapy in older persons. Pertinent issues. Arch Intern Med. 2004;162:1329–1331. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
